Literature DB >> 23898843

Therapeutic implications for NMDA receptors in mood disorders.

Kenji Hashimoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23898843     DOI： 10.1586/14737175.2013.811894

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN： 1473-7175            Impact factor:   4.618


× No keyword cloud information.
  5 in total

1.  The R-Stereoisomer of Ketamine as an Alternative for Ketamine for Treatment-resistant Major Depression.

Authors:  Kenji Hashimoto
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-04-24       Impact factor: 2.582

2.  Regulation of glutamate transporter 1 via BDNF-TrkB signaling plays a role in the anti-apoptotic and antidepressant effects of ketamine in chronic unpredictable stress model of depression.

Authors:  Wen-Xue Liu; Jing Wang; Ze-Min Xie; Ning Xu; Guang-Fen Zhang; Min Jia; Zhi-Qiang Zhou; Kenji Hashimoto; Jian-Jun Yang
Journal:  Psychopharmacology (Berl)       Date:  2015-10-29       Impact factor: 4.530

3.  Antidepressant effects of TrkB ligands on depression-like behavior and dendritic changes in mice after inflammation.

Authors:  Ji-chun Zhang; Jin Wu; Yuko Fujita; Wei Yao; Qian Ren; Chun Yang; Su-xia Li; Yukihiko Shirayama; Kenji Hashimoto
Journal:  Int J Neuropsychopharmacol       Date:  2014-10-31       Impact factor: 5.176

4.  Antidepressant Effects of Ketamine on Depression-like Behavior in Juvenile Mice after Neonatal Dexamethasone Exposure.

Authors:  Su-Xia Li; Ji-Chun Zhang; Jin Wu; Kenji Hashimoto
Journal:  Clin Psychopharmacol Neurosci       Date:  2014-08-12       Impact factor: 2.582

Review 5.  The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders.

Authors:  Daniel Peterlik; Peter J Flor; Nicole Uschold-Schmidt
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.